EV/EBITDA
317.37
+6.58+2.12%
8 min ago
Summary
- As of March 12, 2025, BPMC EV/EBITDA is 317.37, with a rise of +6.58 (+2.12%) during the most recent trading day.
- Over the past year, BPMC EV/EBITDA has increased by +329.37 (+2744.75%).
- BPMC EV/EBITDA is now -21.07% below its all-time high of 402.09.
Performance
BPMC EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
BPMC EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +2.1% | +2.1% | +2.3% |
1 m1 month | -13.0% | -13.0% | -13.7% |
3 m3 months | +483.0% | -2.5% | -3.0% |
6 m6 months | +978.2% | +5.8% | +6.3% |
ytdytd | +2.7% | +2.7% | +2.6% |
1 y1 year | +2744.8% | +6.9% | +0.9% |
5 y5 years | +4429.7% | +133.9% | +84.6% |
BPMC EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -13.0% | 307.10 | +3.3% | |
3 m | 3-month | 402.09 | -21.1% | -86.69 | +466.1% |
6 m | 6-month | 402.09 | -21.1% | -91.63 | +446.4% |
1 y | 1-year | 402.09 | -21.1% | -91.63 | +446.4% |
3 y | 3-year | 402.09 | -21.1% | -91.63 | +446.4% |
5 y | 5-year | 402.09 | -21.1% | -91.63 | +446.4% |
alltime | all time | 402.09 | -21.1% | -91.63 | +446.4% |
Blueprint Medicines EV/EBITDA History
Date | Value |
---|---|
2025 | 317.37(+2.7%) |
2024 | 309.04(-6293.2%) |
2022 | -4.99(-49.1%) |
2021 | -9.81(-152.5%) |
2020 | 18.67(-269.1%) |
Date | Value |
---|---|
2019 | -11.04(+15.5%) |
2018 | -9.56(-50.7%) |
2017 | -19.40(+54.5%) |
2016 | -12.56(+14.4%) |
2015 | -10.98 |
FAQ
- What is Blueprint Medicines EV/EBITDA?
- What is the all time high EV/EBITDA for Blueprint Medicines?
- What is BPMC EV/EBITDA year-to-date change?
- What is Blueprint Medicines EV/EBITDA year-on-year change?
What is Blueprint Medicines EV/EBITDA?
The current EV/EBITDA of BPMC is 317.37
What is the all time high EV/EBITDA for Blueprint Medicines?
Blueprint Medicines all-time high EV/EBITDA is 402.09
What is BPMC EV/EBITDA year-to-date change?
Blueprint Medicines EV/EBITDA has changed by +8.33 (+2.70%) since the beginning of the year
What is Blueprint Medicines EV/EBITDA year-on-year change?
Over the past year, BPMC EV/EBITDA has changed by +329.37 (+2744.75%)